0001333277-18-000032.txt : 20180126 0001333277-18-000032.hdr.sgml : 20180126 20180126174610 ACCESSION NUMBER: 0001333277-18-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180124 FILED AS OF DATE: 20180126 DATE AS OF CHANGE: 20180126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weiland Robert J. CENTRAL INDEX KEY: 0001670648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 18553025 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 7999 GATEWAY BLVD., SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-24 0001042074 CymaBay Therapeutics, Inc. CBAY 0001670648 Weiland Robert J. C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BOULEVARD NEWARK CA 94560 1 0 0 0 Stock Option (right to buy) 11.69 2018-01-24 4 A 0 16000 0 A 2028-01-23 Common Stock 16000 16000 D The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018. /s/ Sujal Shah, as attorney-in-fact 2018-01-26